HCV-086

DB05884ExperimentalSmall molecule

HCV-086 is a small molecule antiviral designed to block an enzyme required for the replication of the hepatitis C virus.

Mechanism: This drug inhibits polymerase enzyme which encourages hepatitis C virus (HCV) infections.
Curator reviewed
Primary indication: Investigated for use/treatment in hepatitis (viral, C).Curator reviewed
Formula / weight: C₂₀H₂₁FN₂O₅S · 420.455 g/mol (avg)
Code names: HCV-086

Resolves to

Compound

Structure

InChIKeyVBRUONUESYTIDA-UHFFFAOYSA-NSMILESCNC(=O)C1=C(OC2=CC(NS(C)(=O)=O)=C(OC(C)C)C=C12)C1=CC=C(F)C=C1

Targets

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with HCV-086, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.